GLP1 Medication: Key Questions to Consider

Thinking about GLP1 medication? Here are key questions to consider before speaking with a licensed provider about your options.

Key takeaways
  • GLP1 medications are prescription treatments that may be recommended based on your health history.
  • Only a licensed healthcare provider can determine if a GLP1 medication is appropriate for you.
  • Not all GLP1 medications are FDA-approved for the same uses, so it’s important to verify what you’re being prescribed.
  • Eden connects patients with independent, licensed healthcare providers who specialize in metabolic health.

This content is for informational purposes only and does not constitute medical advice. Medications like semaglutide are only prescribed when clinically appropriate and are dispensed through state-licensed pharmacies. Eden is not a pharmacy or healthcare provider.

GLP1 medications like semaglutide have become widely discussed for their role in supporting metabolic health. But before starting any new treatment, especially one that affects critical systems like appetite regulation and blood sugar, it’s essential to understand how it works, whether it’s appropriate for you, and what to expect.

If you’re considering a GLP1 medication and want to make an informed decision, asking the right questions can help guide your conversation with a licensed healthcare provider. This article highlights the most important things to consider before beginning treatment, from eligibility to safety to long-term care.

Is GLP-1 Treatments right for you?

Is GLP-1 Treatments right for you?

Get started

What Is a GLP1 Medication?

GLP1 stands for glucagon-like peptide-1, which is a hormone the body produces naturally. It helps regulate blood sugar, slows digestion, and plays a role in appetite signaling. A GLP1 medication is a prescription treatment that mimics this hormone’s action in the body.

Some GLP1 medications, such as semaglutide (available under brand names like Ozempic®, Wegovy®, and Rybelsus®), have received FDA approval for specific conditions, including type 2 diabetes (Ozempic® and Rybelsus®) and chronic weight management (Wegovy®) in individuals who meet medical criteria. Others, including Mounjaro® and Zepbound® (tirzepatide), act on both the GLP1 and GIP receptors and are FDA-approved for specific indications related to type 2 diabetes and chronic weight management, respectively.

The decision to prescribe a GLP1 medication depends entirely on a licensed healthcare provider’s evaluation of your health profile.

{{primary-cta}}

What Should I Ask Before Starting a GLP1 Medication?

Before starting a GLP1 medication, it’s important to ask questions that clarify whether it’s clinically appropriate, how the treatment works, and what ongoing care may be needed. Here are some key questions to consider bringing to your provider:

  1. Am I eligible for a GLP1 medication?
    Eligibility typically depends on factors such as BMI, medical history, and lab results.

  2. Which GLP1 medications are available through this platform?
    Make sure the medication you are prescribed is dispensed through a state-licensed pharmacy, and ask your provider about the approval status and intended use of the medication.

  3. What are the possible side effects or safety considerations?
    Nausea, fatigue, or digestive changes are among the most reported effects and should be monitored closely by your provider.

  4. How will my progress be monitored?
    Ongoing follow-up is often necessary to evaluate how your body responds and to make any dose adjustments.

  5. What lifestyle changes should I plan to make alongside treatment?
    Clinical care typically works best when it includes a combination of medication, nutrition, and activity planning.

Asking these questions can help ensure that your care is grounded in clinical evidence and tailored to your specific health needs.

Are All GLP-1 Medications the Same?

No. While many GLP1 medications interact with similar biological pathways, they differ in their active ingredients, FDA-approved uses, and how they are administered.

For example:

  • Wegovy® (semaglutide) is FDA-approved for chronic weight management in adults with obesity or those who are overweight with at least one weight-related condition.
  • Ozempic® (semaglutide) is approved for improving blood sugar in adults with type 2 diabetes.
  • Rybelsus® (oral semaglutide) is also approved for type 2 diabetes.
  • Mounjaro® (tirzepatide) is FDA-approved to improve glycemic control in adults with type 2 diabetes.
  • Zepbound® (tirzepatide) is FDA-approved for chronic weight management in adults with obesity or those who are overweight with a weight-related condition.

When evaluating any GLP1 treatment program, consider the following:

  • Ensure the prescription follows a consultation with a licensed healthcare provider who evaluates your medical history and health goals.
  • Ask your provider about the medication's approval status and how it fits into your personalized care plan.
  • Confirm that any prescribed medication is dispensed through a state-licensed pharmacy.
  • Request clear information about the specific medication you may receive, including how it supports your overall treatment strategy.

{{primary-cta}}

How Is a GLP1 Medication Prescribed?

A GLP1 medication is only prescribed after a clinical consultation with a licensed healthcare provider. This may include:

  • Reviewing your medical history
  • Discussing your current health goals
  • Conducting lab work (if necessary)
  • Evaluating risk factors and potential contraindications

If the provider determines a GLP1 is appropriate, they will issue a prescription to a state-licensed pharmacy that dispenses the medication. Some patients may begin at a lower dose and increase over time, depending on how they respond.

On the Eden platform, independent licensed healthcare providers handle all treatment decisions. Eden does not prescribe or distribute medication.

What Type of Support Will I Need While Taking a GLP1 Medication?

Ongoing support may be an important part of treatment. Patients may benefit from:

  • Ongoing communication with their provider to monitor symptoms and results
  • Nutrition and movement guidance to complement the effects of the medication
  • Regular check-ins and lab work when recommended by a provider to assess metabolic markers over time

GLP1 medications are not quick fixes. They are part of a broader strategy that may include sustainable behavior change and long-term provider oversight.

Patients who have success with GLP1 treatment often engage in structured care models that help them stay accountable and supported. Always ask what kind of follow-up care is included with any program you consider.

{{primary-cta}}

What Should I Look for in a GLP1 Program?

If you’re comparing programs that offer access to GLP1 medications, consider the following:

  • Is the provider licensed and experienced in metabolic health?
  • Are medications FDA-approved and dispensed by a state-licensed pharmacy?
  • Does the program include ongoing clinical follow-up?
  • Is the cost structure transparent?

Avoid programs that promise fast results or advertise GLP1s without making it clear that a medical evaluation is required. Medications that are not approved by the FDA or sourced from unregulated pharmacies can pose serious risks.

Eden’s Role in GLP1 Access

Eden is a digital platform that connects patients to independent licensed healthcare providers. These providers evaluate your medical history, order labs if needed, and determine whether a GLP1 medication is appropriate for you.

Through Eden, patients may access:

  • A licensed clinical consultation
  • Metabolic health evaluations and optional lab testing
  • Personalized treatment plans
  • Coordination with state-licensed pharmacies

Eden does not make, prescribe, or dispense medications. Its role is to provide access to medical expertise and support your journey toward improved metabolic health through safe, clinically guided care.

Conclusion

GLP1 medications are one tool in the broader landscape of metabolic care, but they require thoughtful consideration and medical oversight. Asking the right questions can help you understand your options and feel confident about the steps ahead.

If you’re ready to explore whether a GLP1 medication may be right for you, Eden makes it easy to connect with independent, licensed healthcare providers who can offer guidance based on your unique health needs.

Start your metabolic health journey with confidence – Connect with a licensed healthcare provider today.

Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.

Eden is not a medical provider or a pharmacy. Eden connects individuals with independent licensed healthcare providers who independently evaluate each patient to determine whether a prescription treatment program is appropriate. All prescriptions are written at the sole discretion of the licensed provider. Medications are filled by independent, state-licensed pharmacies. Eden does not manufacture, own, or dispense any medications. Please consult a licensed healthcare provider before making any medical decisions.

Frequently asked questions

GLP-1 Treatments
Personalized doctor-led plans
As low as $276/mo*
Get started
Important safety information
Verified Customer
"I had an incredible experience, and the support that Eden provides is 10/10"
Kerstin
Verified Customer
“I had so many questions in the beginning, and both the doctor and customer support were so patient and thorough.”
Lane L.

Is GLP-1 Treatments right for you?

Is GLP-1 Treatments right for you?

Get started

References

ClinicalTrials.gov. (n.d.). https://clinicaltrials.gov/study/NCT04184622

Davies, M., Færch, L., Jeppesen, O. K., Pakseresht, A., Pedersen, S. D., Perreault, L., Rosenstock, J., Shimomura, I., Viljoen, A., Wadden, T. A., & Lingvay, I. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971–984. https://doi.org/10.1016/s0140-6736(21)00213-0

Frías, J. P., Davies, M. J., Rosenstock, J., Manghi, F. C. P., Landó, L. F., Bergman, B. K., Liu, B., Cui, X., & Brown, K. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/nejmoa2107519

Wilding, J. P. H., Batterham, R. L., Davies, M., Van Gaal, L. F., Kandler, K., Konakli, K., Lingvay, I., McGowan, B. M., Oral, T. K., Rosenstock, J., Wadden, T. A., Wharton, S., Yokote, K., & Kushner, R. F. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obesity and Metabolism, 24(8), 1553–1564. https://doi.org/10.1111/dom.14725